GLP-1 (Glucagon-Like Peptide-1) receptor agonists have emerged as powerful tools in managing obesity and weight loss
Injected subcutaneously once a week, it is being developed both as a standalone and possibly also in combination, and has the potential to be a best in class therapy for chronic weight management, type 2 diabetes, and could be expanded to other indications
It is not known if Wegovy will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Do not use Wegovy if: you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy Before using Wegovy , tell your healthcare provider if you have any other medical conditions, including if you: have or have had problems with your pancreas or kidneys have type 2 diabetes and a history of diabetic retinopathy have or have had depression, suicidal thoughts, or mental health issues are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation) are pregnant or plan to become pregnant
Strategies for the oral delivery of peptides are broadly categorized into four methods: (1) permeation enhancers (PEs), (2) nanoparticles, (3) lipid-based drug delivery systems (self-emulsifying drug delivery systems (SEDDS)) or hydrophobic ion-pairing, and (4) microneedle devices
If youre on a GLP-1 medication, recovery can look a little different
It is characterized by a cyclic form created by a lactam bridge
